Streamlining Oral Antidiabetic Prescribing Through Clinical Pathway Implementation

https://doi.org/10.22146/jmpf.98056

Susilo Ari Wardani(1*)

(1) *) Master of Nursing, Universitas Muhammadiyah Yogyakarta *) Dinas Kesehatan Provinsi Jawa Timur, Surabaya, 60231
(*) Corresponding Author

Abstract


Background: Diabetes mellitus (DM) is a disease that falls into the high-volume, high-risk, and high-cost categories. A concordance of oral anti-diabetic drug prescribing with the clinical pathway (Pedoman Praktik Klinis, PPK) will ensure drug availability for patients in the universal coverage era.

Objectives: This study aimed to analyze the quantity and quality of antidiabetic drug use before and after PPK implementation, including concordance with the national formulary and PPK.

Methods: This cross-sectional study analyzes oral antidiabetic drug use for inpatient DM (ICD-10 E11) at Sumberglagah Regional Hospital, Mojokerto, East Java Province, Indonesia. Data were collected retrospectively from medical records and the pharmacy database. Drug utilization was presented in Defined Daily Dose per 100 bed-days descriptively.

Results: The quantity of inpatient DM drug use was 189.17 DDD/100 bed-days and 249.42 DDD/100 bed-days, before and after PPK implementation. The types of DM drugs that were included in the 90% DU category, before and after PPK implementation, were Insulin Aspart, Insulin Glargine, Glimepiride tablets, and Insulin Glulisine. The quality of DM drug use was 100% following the National Formulary 2022 and the PPK.

Conclusion: The oral anti-diabetic drugs in the 90% drug cumulative have great attention in the procurement to raise the financial efficiency. The DDD/100 bed-days of anti-diabetic and the number of items of anti-diabetic drugs are increasing, therefore necessitates proactive strategies to manage potential cost escalation for payers, i.e., The Government of Republic Indonesia.


Keywords


drug cumulative percentage; drug use study; quality of drug use

Full Text:

PDF


References

  1. Petersmann A, Müller-Wieland D, Müller UA, Landgraf R, Nauck M, Freckmann G, et al. Clinical Practice Guidelines: Definition, Classification and Diagnosis of Diabetes Mellitus. Exp Clin Endocrinol Diabetes. 2019;127(1):S1–7.
  2. Demir S, Nawroth PP, Herzig S, Ekim Üstünel B. Emerging Targets in Type 2 Diabetes and Diabetic Complications. Adv Sci. 2021;8(18):1–23.
  3. Laakso M. Biomarkers for type 2 diabetes. Mol Metab. 2019;27:S139–46.
  4. Harreiter J, Roden M. Diabetes mellitus—Definition, classification, diagnosis, screening and prevention (Update 2019). Wien Klin Wochenschr. 2019;131(Update):6–15.
  5. Soelistijo SA, Lindarto D, Decroli E, Permana H, Sucipto KW, Kusnadi Y et. al. Pedoman pengelolaan dan pencegahan diabetes melitus tipe 2 di Indonesia 2021. 2021;46.
  6. Artasensi A, Pedretti A, Vistoli G, Fumagalli L. Type 2 Diabetes Mellitus : A Review of Multi-Target Drugs. 2020;1–20.
  7. Cole JB. Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol.
  8. Amalia; Andayani, TM, Yuniarti E. Hubungan Komplikasi Diabetes Melitus Terhadap Biaya Terapi. 2015;159–70.
  9. Ramdini DA. Evaluasi rasionalitas Penggunaan Obat Diabetes mellitus Tipe II Pada pasien Rawat Jalan Di Puskesmas Pasir Sakti Tahun 2019. J Farm Lampung JFL. 2020;(1):69–77.
  10. Kementrian Kesehatan Republik Indonesia. Kepmenkes RI Nomor. HK.01.07/MENKES/1128/2022 tentang Standar Akreditasi Rumah Sakit April 2022.
  11. Sutoto, Sastroasmoro S, Budiwaluyo W. Pedoman Penyusunan Panduan Praktik Klinis Dan Clinical Pathways Dalam Asuhan Terintegrasi Sesuai dengan Standar Akreditasi Rumah Sakit 2012. 2015;1–234.
  12. Bierbaum M, Rapport F, Arnolda G, Nic Giolla Easpaig B, Lamprell K, Hutchinson K, et al. Clinicians’ attitudes and perceived barriers and facilitators to cancer treatment clinical practice guideline adherence: A systematic review of qualitative and quantitative literature. Implement Sci. 2020;15(1):1–24.
  13. Ryan MA. Adherence to Clinical Practice Guidelines. 2017;2–4.
  14. Wang W, Choi D, Yu CH. Effective web-based clinical practice guidelines resources: recommendations from a mixed methods usability study. BMC Prim Care. 2023;24(1):1–10.
  15. Nugraha NE. Implementasi Panduan Praktik Klinis Dalam Menurunkan Variasi Pelayanan Pada Tindakan Sectio Caesarea Di PKU Muhamadiyah Gamping. 2018;1–26
    1. Adhi, Sigid Nugroho; Puspita Ningsih K. Manajemen Data Standar Pelayanan Minimal Rumah Sakit The Hospital Minimum Service Standard Data Management Studi Rekam Medis dan Informasi Kesehatan Fakultas Kesehatan Universitas Jenderal Achmad Yani Yogyakarta satunya adalah Standar Pelayanan Minimal Tu. 2020;3(2):53–62.
  16. Kementrian Kesehatan Republik Indonesia. Kepmenkes RI Nomor. HK.01.07/MENKES/200/2020 tentang Pedoman Penyusunan Formularium Rumah Sakit. 2020;1–16.
  17. Kementrian Kesehatan Republik Indonesia. Peraturan Menteri Kesehatan Republik Indonesia Nomor 72 Tahun 2016 Tentang Standar Pelayanan Kefarmasian Di Rumah Sakit. 2016;147(March):1–63.
  18. Kementerian Kesehatan Republik Indonesia. Petunjuk Teknis Evaluasi Penggunaan Obat di Fasilitas Kesehatan. 2015;1–47.
  19. Menteri Kesehatan Republik Indones. Menkes RI Nomor: 129/Menkes/SK/II/2008 tentang Standart Pelayanan Minimal Rumah Sakit. 2008;1–55.
  20. Menteri Kesehatan Republik Indones. Permenkes RI Nomor 54 Tahun 2018 tentang Penyusunan dan Penerapan Formularium Nasional dalam Penyelenggaraan Program Jaminan Kesehatan. 2018;1–55.
  21. Pratiwi WR, Kautsar AP, Gozali D. Hubungan Kesesuaian Penulisan Resep dengan Formularium Nasional Terhadap Mutu Pelayanan pada Pasien Jaminan Kesehatan Nasional di Rumah Sakit Umum di Bandung Relationship between the prescription suitability with the National of care in General Hospital i. 2017;00:48–56.
  22. Pratiwi A. Evaluasi Kesesuaian Peresepan Obat Pada Pasien Bpjs Rawat Jalan Poli Penyakit Dalam Terhadap Formularium Nasional Di Rsud Kabupaten Bengkulu Selatan. 2020;
  23. Sa’diyah H, Nuraini A. Profil Kesesuaian Peresepan Obat Pasien BPJS Dengan Formularium Nasional di Puskesmas Bangkalan Periode Januari-Maret 2020. Indones J Pharm Herb Med. 2021;1(1):5–9.
  24. Lahiry S, Kundu A, Mukherjee A, Choudhury S, Sinha R. Analyzing Antidiabetes Drug Prescriptions With World Health Organization Anatomical Therapeutic Chemical/Defined Daily Dose Index to Assess Drug Utilization Pattern in Elderly Population of Rural Eastern India. Indian Journal of Clinical Medicine. 2017;8. doi:10.1177/1177393617703343
  25. Tim Riskesdas 2018. Laporan Nasional Riskesdas 2018. Lembaga Penerbit Badan Penelitian dan Pengembangan Kesehatan. 2019;
  26. Kautzky-Willer A, Harreiter J, Pacini G. Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus. Endocr Rev. 2016;37(3):278-316. doi:10.1210/er.2015-1137.
  27. Ciarambino T, Crispino P, Leto G, Mastrolorenzo E, Para O, Giordano M. Influence of Gender in Diabetes Mellitus and Its Complication. Int J Mol Sci. 2022;23(16):8850. Published 2022 Aug 9. doi:10.3390/ijms23168850.
  28. Bellary, S., Kyrou, I., Brown, J.E. et al. Type 2 diabetes mellitus in older adults: clinical considerations and management. Nat Rev Endocrinol 17, 534–548 (2021). https://doi.org/10.1038/s41574-021-00512-2.
  29. Coetzee A. An introduction to insulin use in type 2 diabetes mellitus. S Afr Fam Pract (2004). 2023;65(1):e1-e5. Published 2023 Apr 20. doi:10.4102/safp.v65i1.5702.
  30. Emad-Eldin M, Balata GF, Elshorbagy EA, Hamed MS, Attia MS. Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges. World J Diabetes. 2024;15(5):828-852. doi:10.4239/wjd.v15.i5.828.
  31. Kurniati N 2017. Kesesuaian Pemberian Antibiotik Demam Tifoid Anak Di Unit Rawat Inap Rumah Sakit Umum Aminah Blitar Tahun 2017. Amin Public Hosp Blitar. 2017;8(1):1–12.



DOI: https://doi.org/10.22146/jmpf.98056

Article Metrics

Abstract views : 1091 | views : 480

Refbacks

  • There are currently no refbacks.


Copyright (c) 2025 JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

©Jurnal Manajemen dan Pelayanan Farmasi
Faculty of Pharmacy
Universitas Gadjah Mada
Creative Commons License
View My Stats